Lightning Round: Jim Cramer Weighs In On Juno Therapeutics, Halliburton And More
August 18, 2017 at 07:54 AM EDT
On CNBC's "Mad Money Lightning Round", Jim Cramer said Juno Therapeutics Inc(NASDAQ: JUNO) is a high risk immunotherapy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.